<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fiege JK</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>U.S. Department of Health and Human Services</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>1815-1827.e6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8665115</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(12)</volume><pubmed_abstract>Laboratory mice comprise an expeditious model for preclinical vaccine testing; however, vaccine immunogenicity in these models often inadequately translates to humans. Reconstituting physiologic microbial experience to specific pathogen-free (SPF) mice induces durable immunological changes that better recapitulate human immunity. We examined whether mice with diverse microbial experience better model human responses post vaccination. We co-housed laboratory mice with pet-store mice, which have varied microbial exposures, and then assessed immune responses to influenza vaccines. Human transcriptional responses to influenza vaccination are better recapitulated in co-housed mice. Although SPF and co-housed mice were comparably susceptible to acute influenza infection, vaccine-induced humoral </pubmed_abstract><journal>Cell host &amp; microbe</journal><pubmed_title>Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.</pubmed_title><pmcid>PMC8665115</pmcid><funding_grant_id>75N93019C00051</funding_grant_id><funding_grant_id>R01 AI132962</funding_grant_id><funding_grant_id>R01 AI116678</funding_grant_id><funding_grant_id>R01 AI150600</funding_grant_id><funding_grant_id>R01 AI143828</funding_grant_id><funding_grant_id>T32 HL007741</funding_grant_id><funding_grant_id>HHSN272201400005C</funding_grant_id><pubmed_authors>Mickelson CK</pubmed_authors><pubmed_authors>Shepherd FK</pubmed_authors><pubmed_authors>Matchett WE</pubmed_authors><pubmed_authors>Meyerholz DK</pubmed_authors><pubmed_authors>Stolley JM</pubmed_authors><pubmed_authors>Nanda H</pubmed_authors><pubmed_authors>Hamilton SE</pubmed_authors><pubmed_authors>Block KE</pubmed_authors><pubmed_authors>Fiege JK</pubmed_authors><pubmed_authors>Langlois RA</pubmed_authors><pubmed_authors>Vezys V</pubmed_authors><pubmed_authors>Wijeyesinghe S</pubmed_authors><pubmed_authors>Pierson MJ</pubmed_authors><pubmed_authors>Shen SS</pubmed_authors><pubmed_authors>Masopust D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.</name><description>Laboratory mice comprise an expeditious model for preclinical vaccine testing; however, vaccine immunogenicity in these models often inadequately translates to humans. Reconstituting physiologic microbial experience to specific pathogen-free (SPF) mice induces durable immunological changes that better recapitulate human immunity. We examined whether mice with diverse microbial experience better model human responses post vaccination. We co-housed laboratory mice with pet-store mice, which have varied microbial exposures, and then assessed immune responses to influenza vaccines. Human transcriptional responses to influenza vaccination are better recapitulated in co-housed mice. Although SPF and co-housed mice were comparably susceptible to acute influenza infection, vaccine-induced humoral </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-09T22:38:40.96Z</modification><creation>2025-02-19T03:26:21.098Z</creation></dates><accession>S-EPMC8665115</accession><cross_references><pubmed>34731647</pubmed><doi>10.1016/j.chom.2021.10.001</doi></cross_references></HashMap>